The Boston Globe
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
Moderna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the United States. Moderna chief executive Stéphane Bancel swats away the skepticism, portraying ...
3 days ago